[2] [11] As of 2026, retatrutide has not received marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA), and it remains an experimental compound available only within authorised clinical trial settings
Truthmeter: 3 (out of 10) Truthmeter and contact info Fact Checker columns by Mark Robison are rated on a scale from 0 to 10, with 10 being absolutely true with no gray area, 5 being down the middle with good points by both sides, 1 being false with no gray area and 0 being intentionally, maliciously or foolishly false
10.1089/acm.2006.12.881 Summary Keywords vitamin B12, efficacy, bioavailability, therapeutic approaches, meta-analysis, cobalamin Citation Mazur M, Ndokaj A, Salerno C, Vallone J, Ardan R, Bietolini S, Carrouel F, Wilk A, Sarig R, Ottolenghi L and Bourgeois D (2025) Efficacy of sublingual and oral vitamin B12 versus intramuscular administration: insights from a systematic review and meta-analysis
If you do not see improvement after a few months, consult your healthcare provider
are offering them
The standard diagnostic pathway includes a serum B12 blood test as the initial screening tool
